Santhera raises EUR 10 million

Musculoskeletal and endocrine company Santhera (Liestal, Switzerland) raised EUR 10 million ($12.7 million) in a series C round led by NGN Capital. New investors NeoMed Management; Schroder Investment Management; and BioMedinvest were joined by existing investors Carnegie Asset Management; GIMV; Dow Chemical; Clariden Biotechnology Fund; and 3i Group and other investors. Santhera also said it has an option to call an additional EUR 5 million ($6.4 million). ...